Cerity Partners’s GMO US Value ETF GMOV Stock Holding History

Cerity Partners’s Portfolio GMOV Stock Details GMOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.26M	Sell	39,934 -6,850	-15%	-$219K	﹤0.01%	1868
2026 Q2	$1.39M	Sell	46,784 -6,685	-13%	-$198K	﹤0.01%	1785
2026 Q1	$1.5M	Sell	53,469 -44,260	-45%	-$1.26M	﹤0.01%	1633
2025 Q4	$2.69M	Hold	97,729	–	–	﹤0.01%	1241
2025 Q3	$2.58M	Hold	97,729	–	–	﹤0.01%	1170
2025 Q2	$2.47M	Hold	97,729	–	–	﹤0.01%	1118
2025 Q1	$2.4M	Hold	97,729	–	–	﹤0.01%	1028
2024 Q4	$2.39M	Buy	+97,729	New	+$2.47M	0.01%	1024

Other funds holding GMOV

Commerce Advisors Memphis, Tennessee $212M AUM

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $46.6B AUM 32.12% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

Legacy Capital Wealth Partners Little Rock, Arkansas $481M AUM 19.97% 1-Year Est. Return

Fund Evaluation Group Cincinnati, Ohio $4.22B AUM 10.75% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $32.8B AUM 18.62% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $627M AUM 18.86% 1-Year Est. Return

J.W. Cole Advisors Tampa, Florida $5.93B AUM 23.96% 1-Year Est. Return

Cerity Partners's GMOV Position: Q3 2026 in Review

Cerity Partners reduced its GMO US Value ETF (GMOV) stake by 15% in Q3 2026, selling an estimated $219K and leaving 39,934 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1868.

Cerity Partners first reported a position in GMOV in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.69M in Q4 2025. 22 funds tracked by Wall St. Rank hold GMOV as of Q3 2026.

Cerity Partners held 39,934 shares of GMO US Value ETF worth $1.26M as of Q3 2026.
Cerity Partners sold 6,850 GMO US Value ETF shares in Q3 2026, an estimated $219K.
GMO US Value ETF made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #1868 holding.
Cerity Partners first reported a position in GMO US Value ETF in Q4 2024 and has held it in 8 quarters since.
Cerity Partners's GMO US Value ETF position peaked at $2.69M in Q4 2025.
22 funds tracked by Wall St. Rank held GMO US Value ETF as of Q3 2026.

Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.